Veteran investor and operating executive focused on growth-stage technology and financial services. Jonathan R. Weatherly is known for leading private equity and corporate development initiatives, sourcing buyouts and growth investments and working closely with management teams to scale revenue and optimize capital structure. Active across direct investing, fund advisory and board roles, often emphasizing operational improvement, go-to-market expansion, and disciplined capital allocation. Market-facing profile suits LPs and strategic acquirers seeking an experienced deal partner.
Veteran investor and operating executive focused on growth-stage technology and financial services. Jonathan R. Weatherly is known for leading private equity and corporate development initiatives, sourcing buyouts and growth investments and working closely with management teams to scale revenue and optimize capital structure. Active across direct investing, fund advisory and board roles, often emphasizing operational improvement, go-to-market expansion, and disciplined capital allocation. Market-facing profile suits LPs and strategic acquirers seeking an experienced deal partner.
Focuses on growth-stage technology and financial services with a bias toward investments where operational intervention can accelerate revenue and margin expansion. Prioritizes buyouts and growth rounds that allow for capital-structure optimization and clear governance levers, partnering closely with founders and management to execute go-to-market scaling, cost discipline, and KPI-driven milestones. Employs staged capital deployment, active board oversight, and performance-linked incentives to manage downside while targeting durable cash-flow conversion; prefers control or influential minority positions and often blends direct dealmaking with fund advisory and co-investments.
Focuses on growth-stage technology and financial services with a bias toward investments where operational intervention can accelerate revenue and margin expansion. Prioritizes buyouts and growth rounds that allow for capital-structure optimization and clear governance levers, partnering closely with founders and management to execute go-to-market scaling, cost discipline, and KPI-driven milestones. Employs staged capital deployment, active board oversight, and performance-linked incentives to manage downside while targeting durable cash-flow conversion; prefers control or influential minority positions and often blends direct dealmaking with fund advisory and co-investments.
| Trades 2017 | Longs Won 1348/2017 66% | Profit Factor 5.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $361,583.18 |
| Average Win $146,024.65 | Best Trade (Aug 17) $8.52M | Sharpe Ratio -10.18 |
| Average Loss -$54,217.08 | Worst Trade (Dec 31) -$1.92M | Z-Score 9.61 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 1w 3d | Expectancy $79,608.33 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 11,905 | 10,714 | 9,524 | 8,333 | 7,143 | 5,952 | 4,762 | 3,571 | 2,381 | 1,190 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 61,540 | $11.79M | $19.01M | - | $7.22M | 61.3% | -7.354% |
ABBV AbbVie Inc. | 6,000 | $1.14M | $1.51M | - | $363,591.79 | 31.84% | -2.513% |
AFL Aflac Inc. | 12,711 | $1.29M | $1.62M | - | $327,638.37 | 25.34% | +0.094% |
AMAT Applied Materials, Inc. | 11,939 | $2.22M | $6.06M | - | $3.84M | 172.59% | +1.176% |
AMD Advanced Micro Devices, Inc. | 4,350 | $2.53M | $2.07M | - | -$455,706.54 | -18.03% | -1.904% |
AMGN Amgen Inc. | 8,937 | $2.54M | $3.44M | - | $899,929.91 | 35.4% | -0.64% |
AMZN Amazon.com Inc | 38,597 | $7.03M | $10.48M | - | $3.45M | 49.12% | +15.321% |
AVEM Avantis Emerging Markets Equity ETF | 233,739 | $14.32M | $20.92M | - | $6.6M | 46.13% | +0.101% |
AVGO Broadcom Inc. | 32,064 | $4.54M | $12.48M | - | $7.94M | 174.64% | +0.371% |
AVLV Avantis U.S. Large Cap Value ETF | 78,094 | $4.24M | $7.2M | - | $2.95M | 69.58% | +0.141% |
AVUV Avantis U.S. Small Cap Value ETF | 86,904 | $7.68M | $10.89M | - | $3.21M | 41.8% | +0.032% |
BAC Bank of America Corporation | 28,063 | $1.18M | $1.74M | - | $554,965.26 | 46.89% | +0.356% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 46,391 | $4.25M | $4.25M | - | -$50.79 | - | +0.033% |
BLK BlackRock, Inc. | 993 | $969,358.4 | $1.08M | - | $113,398.88 | 11.7% | -0.727% |
BMY Bristol-Myers Squibb Company | 19,057 | $1.01M | $1.24M | - | $239,494.15 | 23.83% | +0.694% |
BND Vanguard Total Bond Market Index Fund | 4,605 | $338,053 | $332,619.15 | - | -$5,433.85 | -1.61% | -0.262% |
BRK-B Berkshire Hathaway Inc. | 455 | $224,030 | $232,750.7 | - | $8,720.7 | 3.89% | +0.365% |
C Citigroup Inc. | 12,020 | $637,254.83 | $1.59M | - | $954,794.17 | 149.83% | +0.098% |
CAT Caterpillar Inc. | 8,092 | $3.11M | $6.59M | - | $3.48M | 112.05% | +0.701% |
CB Chubb Limited | 8,257 | $2.23M | $2.9M | - | $662,060.89 | 29.64% | +0.151% |